Pfizer Inc. (NYSE: PFE) has completed its acquisition of Metsera Inc. (NASDAQ: MTSR), a clinical-stage biopharmaceutical company focused on obesity ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE